Who is Eileen Goodwin from Jeopardy? Meet the Boston Scientist Researching Vaccines, Viruses and the Immune System

Eileen Goodwin is a research scientist from Boston, Massachusetts, appearing on Jeopardy! with a background in immunology, virology and infectious-disease research.

Her scientific work focuses on how the immune system responds to viruses and how previous infections or vaccinations influence future immune responses.

She earned a Ph.D. in Immunology from the University of Pennsylvania’s Perelman School of Medicine in December 2024.

Before completing her doctorate, Goodwin had already contributed to published research involving influenza, respiratory syncytial virus, Zika virus, Ebola-family viruses and coronaviruses.

Eileen Goodwin Earned Her PhD at the University of Pennsylvania

Goodwin completed her doctoral studies through the University of Pennsylvania’s Immunology Graduate Group.

Her dissertation was titled “The Impact of Prior Immunity on B Cell Responses to Viral Antigens.”

She was co-mentored by researchers Scott Hensley and Laurence Eisenlohr.

Her work examined how the immune system’s previous experiences can influence its response to later infections and vaccinations.

Her Research Examined How Antibodies Affect Vaccination

One important part of Goodwin’s doctoral research focused on influenza.

She studied what happens when the body already has antibodies against influenza before receiving a vaccine.

Using experimental mouse models, she investigated how existing antibodies influence the formation of new immune responses.

Her research examined B cells, plasmablasts and germinal-center activity, all of which are involved in the development of antibody-mediated immunity.

What Is Immune Imprinting?

Goodwin’s research connects with the phenomenon known as immune imprinting.

The concept describes how earlier encounters with a virus can shape the immune system’s response to later encounters with related viruses.

For example, previous influenza infections or vaccinations may influence how the body responds to a different influenza strain.

Understanding those effects is important when researchers attempt to develop vaccines that produce broad and effective protection.

Eileen Goodwin Also Studied Coronaviruses

Her doctoral research extended beyond influenza.

Goodwin participated in studies examining how antibodies against seasonal coronaviruses might affect responses to SARS-CoV-2.

Researchers investigated whether previous coronavirus exposure influenced immune responses or clinical outcomes during COVID-19 infection.

She also contributed to research involving pediatric COVID-19 and multisystem inflammatory syndrome in children, commonly known as MIS-C.

She Previously Worked at Biotechnology Company Adimab

Before entering the University of Pennsylvania doctoral program, Goodwin worked at Adimab in Lebanon, New Hampshire.

The biotechnology company specializes in antibody discovery and engineering.

At Adimab, she contributed to research examining antibodies generated in response to several important viral infections.

The experience gave her substantial practical exposure to antibody characterization and infectious-disease research before graduate school.

Her Research Included Respiratory Syncytial Virus

One area of Goodwin’s work involved respiratory syncytial virus, or RSV.

She participated in studies investigating how infants generate neutralizing antibodies after infection.

The research was significant because infants have relatively immature immune systems but can still produce antibodies capable of targeting important viral structures.

Goodwin also contributed to work examining antibody responses in adults previously infected with RSV.

Goodwin Studied Zika and Dengue Immunity

Another research project investigated the relationship between Zika virus and dengue virus.

Because the viruses are related, antibodies generated against one may recognize components of the other.

Goodwin participated in research examining how previous dengue exposure influences the B-cell response to Zika.

The work addressed questions about cross-reactive immunity and the development of new antibodies.

She Contributed to Ebola Antibody Research

Goodwin also worked on studies involving Ebola and related ebolaviruses.

The research included identifying human antibodies capable of neutralizing multiple members of the ebolavirus group.

Some studies examined antibodies obtained from Ebola survivors.

Researchers investigated how those antibodies recognize conserved regions of viral proteins, knowledge that may help inform antibody-based treatment development.

Eileen Goodwin’s Scientific Career Has a Consistent Theme

Although Goodwin has studied several different viruses, her research has consistently centered on antibodies and immune memory.

Her work asks how the immune system responds to a virus, what it remembers afterward and how that memory changes future responses.

Her Jeopardy! appearance introduces viewers to a scientist whose career involves some of the most important questions in infectious-disease immunology and vaccine research.